Real-time enrollment status for this hereditary hemorrhagic telangiectasia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:43 AM UTC
| NCT Number | NCT06259292 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Hemorrhagic Telangiectasia |
| Phase | Clinical Trial |
| Target Enrollment | 10,000 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Cure HHT |
| Last Updated on CT.gov | June 13, 2025 (Jun 13, 2025) |
As of July 13, 2026: Clinical trial NCT06259292 is currently recruiting participants. This clinical trial study for hereditary hemorrhagic telangiectasia is actively seeking new participants at 16 locations across the United States. The study is sponsored by Cure HHT. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06259292 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06259292 was last updated Jun 13, 2025 (June 13, 2025). HelloStudys verifies this status automatically.